CD4 and cancer: For biomedical applications, clinical symptoms (such as bleeding episodes), biological markers (e.g. CD4 cell counts or serum immunoglobulin levels), scale of the disease (e.g. stages of cancer or HIV infection), or a non-fatal complication during infection progression (e.g. cancer recurrence) could all be used to classify states [16].